Syntimmune, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://syntimmune.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)A Study of SYNT001 in Healthy Volunteers
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Syntimmune, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT03643627
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States
News
No news found